TrialJournal of bone and mineral metabolism2016

Patient preference for monthly bisphosphonate versus weekly bisphosphonate in a cluster-randomized, open-label, crossover trial: Minodroate Alendronate/Risedronate Trial in Osteoporosis (MARTO).

Jun Iwamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.